Holdings of VanEck Biotech ETF
ISIN US92189F7261
VanEck ETF Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 371.6M $ including 371.3M $ in equities, 99.9 %
- Positions
- 24 in 4 countries
- Top ten
- 70.8 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Gilead Sciences Inc | 390,092 | 54.4M $ | 14.63 % |
| 2 | Amgen Inc | 153,582 | 54M $ | 14.54 % |
| 3 | Vertex Pharmaceuticals Inc | 67,053 | 29.9M $ | 8.06 % |
| 4 | Regeneron Pharmaceuticals, Inc. | 36,132 | 27.9M $ | 7.51 % |
| 5 | Argenx SE | 26,852 | 19.6M $ | 5.28 % |
| 6 | Insmed Inc | 104,290 | 17.1M $ | 4.59 % |
| 7 | IQVIA Holdings Inc | 93,651 | 16M $ | 4.30 % |
| 8 | Alnylam Pharmaceuticals Inc | 46,120 | 15.3M $ | 4.11 % |
| 9 | Natera Inc | 73,931 | 14.8M $ | 3.98 % |
| 10 | United Therapeutics Corp | 23,856 | 14.1M $ | 3.81 % |
| 11 | Biogen Inc | 75,443 | 13.8M $ | 3.72 % |
| 12 | BEONE MEDICINES LTD | 40,622 | 12.1M $ | 3.25 % |
| 13 | Moderna Inc | 226,910 | 11.5M $ | 3.10 % |
| 14 | Revolution Medicines Inc | 109,365 | 10.6M $ | 2.86 % |
| 15 | Illumina Inc | 75,133 | 9.3M $ | 2.49 % |
| 16 | Incyte Corp | 88,766 | 8.4M $ | 2.25 % |
| 17 | BioNTech SE | 90,077 | 8M $ | 2.15 % |
| 18 | Neurocrine Biosciences Inc | 54,628 | 7.2M $ | 1.94 % |
| 19 | BioMarin Pharmaceutical Inc | 91,597 | 5.2M $ | 1.39 % |
| 20 | Bio-Techne Corp | 95,803 | 5M $ | 1.35 % |
| 21 | Charles River Laboratories International Inc | 27,539 | 4.8M $ | 1.28 % |
| 22 | ICON PLC | 42,718 | 4.7M $ | 1.27 % |
| 23 | QIAGEN NV | 106,309 | 4.3M $ | 1.15 % |
| 24 | Tempus AI Inc | 76,175 | 3.4M $ | 0.93 % |
Sector breakdown
- Health care 82.4 %
- Unattributed 17.6 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 91.3 %
- Netherlands 5.3 %
- Germany 2.2 %
- Ireland 1.3 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 21 | 339M $ | 91.29 % |
| 2 | Netherlands | 1 | 19.6M $ | 5.28 % |
| 3 | Germany | 1 | 8M $ | 2.16 % |
| 4 | Ireland | 1 | 4.7M $ | 1.27 % |
Cite this page
Titelia. "Holdings of VanEck Biotech ETF". https://titelia.com/en/funds/S000034406